29 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Swetter, Dermatologist in Stanford, CA?
Dr. Susan Swetter, MD is a Dermatologist, who primarily practices in Stanford, CA with 2 additional practice locations. She has been practicing for over 29 years and is board certified by the American Board of Dermatology. Dr. Swetter completed her residency at Stanford Univ Hosp, Dermatology; Moffitt Hosp Univ Of Ca, Internal Medicine. Dr. Swetter is fluent in English, and is currently seeing new patients. Dr. Swetter’s practice accepts Medicaid, Medicare, UnitedHealthcare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Swetter’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Swetter?
Dr. Susan Swetter, MD is a highly-rated, board-certified Dermatologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Swetter empowers patients to confidently navigate their health journey, specializing in Melanoma, Pigmented Lesions, Skin Cancer, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Swetter is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Swetter go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Dermatology; Moffitt Hosp Univ Of Ca, Internal Medicine | Stanford University School of Medicine | Stanford University Medical Center
Medical School: University of Pa Sch of Med, Philadelphia Pa
Is Dr. Swetter board certified in Dermatologist?
Yes, Dr. Susan Swetter, MD is board certified by the American Board of Dermatology , American Board of Dermatology since 1994
What languages does Dr. Swetter speak?
Dr. Swetter and their clinical team can communicate with patients in the following languages:
English
What conditions does Dr. Swetter treat?
As a Dermatologist, Dr. Swetter diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Swetter. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Melanoma
- Melanoma of the Trunk
- Melanoma of Scalp or Neck
- Melanoma of the Left Leg or Hip
- Melanoma of Right Leg or Hip
- Melanoma of the Right Arm or Shoulder
- Melanoma of Left Arm or Shoulder
- Facial Melanoma
- Malignant Melanoma
- Skin Cancer (Melanoma)
- Cutaneous Melanoma
- Black Skin Cancer
- Malignant Melanoma of Body
- Skin Cancer on Torso
- Scalp Melanoma
- Neck Melanoma
- Skin Cancer of Scalp
- Skin Cancer of Neck
- Left Leg Melanoma
- Left Hip Melanoma
- Malignant Melanoma of Left Leg
- Right Leg Melanoma
- Right Hip Melanoma
- Skin Cancer of Right Leg
- Right Lower Limb Melanoma
- Right Arm Melanoma
- Right Shoulder Melanoma
- Malignant Melanoma of Right Arm
- Left Arm Melanoma
- Left Shoulder Melanoma
- Skin Cancer of Left Arm
- Left Upper Limb Melanoma
- Malignant Facial Melanoma
- Skin Cancer of Face
- Melanoma on Face
ICD-10 Codes:
- C439: Malignant melanoma of skin, unspecified
- C4359: Malignant melanoma of other part of trunk
- C434: Malignant melanoma of scalp and neck
- C4372: Malignant melanoma of left lower limb, including hip
- C4371: Malignant melanoma of right lower limb, including hip
- C4361: Malignant melanoma of right upper limb, including shoulder
- C4362: Malignant melanoma of left upper limb, including shoulder
- C4330: Malignant melanoma of unspecified part of face
- C4339: Malignant melanoma of other parts of face
Also known as:
- Actinic Keratosis
- Skin Condition
- Sun Exposure
- Skin Cancer Treatment (PDQ®)
- Solar keratosis
- Precancerous skin lesion
- Rough sun spots
ICD-10 Codes:
- L570: Actinic keratosis
Also known as:
- Benign Skin Growth
- Inflamed Seborrheic Keratosis
- Benign Tumor
- Skin Condition
- Non-cancerous skin lesion
- Skin tumor
- Skin lump
- Irritated seborrheic keratosis
- Red skin growth
- Inflamed age spot
ICD-10 Codes:
- D2370: Other benign neoplasm of skin of unspecified lower limb, including hip
- L820: Inflamed seborrheic keratosis
Also known as:
- Benign Skin Tumor
- Benign Trunk Skin Tumor
- Benign Arm or Shoulder Skin Tumor
- Benign Tumor
- Non-cancerous skin growths
- Skin lesions
- Benign skin masses
- Non-cancerous growth on trunk skin
- Trunk skin lesion
- Benign trunk skin mass
- Lump on body skin
- Non-cancerous growth on arm skin
- Arm skin lesion
- Benign shoulder skin mass
- Lump on arm
ICD-10 Codes:
- D239: Other benign neoplasm of skin, unspecified
- D235: Other benign neoplasm of skin of trunk
- D2360: Other benign neoplasm of skin of unspecified upper limb, including shoulder
Also known as:
- Skin Tumor of Uncertain Behavior
- Skin Condition
- Skin Neoplasm
- Skin Growth
- Uncertain Skin Lesion
ICD-10 Codes:
- D485: Neoplasm of uncertain behavior of skin
Also known as:
- Cancer in Lymph Nodes
- Cancer Spread to Unknown Site
- Cancer
- Lymph Node Metastasis
- Metastatic Lymph Node Cancer
- Secondary Lymphoma
- Metastatic Cancer of Unknown Primary
- Secondary Cancer, Unspecified Location
- Cancer of Unknown Origin
ICD-10 Codes:
- C779: Secondary and unspecified malignant neoplasm of lymph node, unspecified
- C799: Secondary malignant neoplasm of unspecified site
Also known as:
- Growth of Unknown Type
- Tumor of uncertain nature
- Lesion of uncertain behavior
- Indeterminate mass
ICD-10 Codes:
- D489: Neoplasm of uncertain behavior, unspecified
Also known as:
- Melanoma
- Malignant Melanoma
- Skin Melanoma
- Melanoma Skin Cancer
ICD-10 Codes:
- Z85820: Personal history of malignant melanoma of skin
Which procedures does Dr. Swetter perform as a Dermatologist?
As a Dermatologist, procedures performed by a Dr. Susan Swetter may include:
- Ambulatory Phlebectomy
- Annual Skin Screening
- Anti-Aging Treatment
- Biopsy
- Botox Follow Up
- Botox Treatment
- Chemical Peel
- Collagen Injection
For detailed information, please contact Dr. Swetter's office.
Does Dr. Swetter accept my insurance?
Dr. Swetter accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Swetter accept in Stanford, CA?
Dr. Swetter in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Alignment Health Plan
All Other Third Party
AllCare Health Plan
Blue Shield of California
CVS Health (formerly Aetna)
Express Scripts
Humana
Medicaid
Medicare
UnitedHealthcare
View All Insurances
Where is Dr. Swetter's office located?
Recognitions
Awards
Franklin G. Ebaugh, Jr. Award (outstanding dedication to advising med
Nominated
Kaiser Award for Clinical Teaching, Stanford University School of Med
Nominated
Stanford University School of Medicine
Recognition for Excellence in Teaching
Melanoma Care Coalition
Leadership Award
Humanitarian Award Recipient, Melanoma Research Foundation
Member, American Dermatological Association
President s Council on Service & Civic Participation, Corporation for
President s Volunteer Service Award
Publications
Melanoma, Version 4.2014 Featured Updates to the NCCN Guidelines
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2014
Pediatric Melanoma: Alysis of an Intertiol Registry
CANCER, 2013
Activating HRAS Mutation in Agmited Spitz Nevi Arising in a Nevus Spilus.
JAMA dermatology, 2013
Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2013
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
TRANSLATIOL ONCOLOGY, 2012
Behavioral determints of successful early melanoma detection
CANCER, 2012
Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling
JOURL OF CLINICAL ONCOLOGY, 2012
Survival Is Not the Only Valuable End Point in Melanoma Screening
JOURL OF INVESTIGATIVE DERMATOLOGY, 2012
Reporting and registering nonmelanoma skin cancers: a compelling public health need
BRITISH JOURL OF DERMATOLOGY, 2012
Melanoma
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2012
Guidelines of care for the magement of primary cutaneous melanoma
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011
Reducing mortality in individuals at high risk for advanced melanoma through education
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011
Melanoma and Melanocytic Tumors of Uncertain Malignt Potential in Children
PEDIATRIC DERMATOLOGY, 2010
Risk of second primary maligncies following cutaneous melanoma diagnosis: A population-based study
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010
Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer
JOURL OF CUTANEOUS PATHOLOGY, 2010
Efficacy of Skin Self-Examition Practices for Early Melanoma Detection
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009
Selection criteria for genetic assessment of patients with familial melanoma
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009
Increasing Burden of Melanoma in the United States
JOURL OF INVESTIGATIVE DERMATOLOGY, 2009
Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis
JOURL OF CUTANEOUS PATHOLOGY, 2009
Impaired interferon sigling is a common immune defect in human cancer
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2009
Melanoma in Middle-aged
ARCHIVES OF DERMATOLOGY, 2009
Melanoma
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2009
High-molecular-weight keratin stain as a complement to Melan A stain
JOURL OF CUTANEOUS PATHOLOGY, 2008
Melanoma underreporting: Why does it happen, how big is the problem, and how do we fix it?
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008
California medicaid Enrollment and melanoma stage at diagnosis - A population-based study
AMERICAN JOURL OF PREVENTIVE MEDICINE, 2008
Screening, early detection
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007
Evaluation of digital dermoscopy in a pigmented lesion clinic
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007
Crafting a melanoma educatiol campaign to reach middle-aged and older men
JOURL OF CUTANEOUS MEDICINE AND SURGERY, 2006
Use of artificial tanning products among young adults
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006
Sun care advertising in popular US magazines
AMERICAN JOURL OF HEALTH PROMOTION, 2006
A call for the development and implementation of a targeted tiol melanoma screening program
ARCHIVES OF DERMATOLOGY, 2006
Sun protection factor content and warning statements for sunless tanning products
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005
Increasing incidence of lentigo malig melanoma subtypes
JOURL OF INVESTIGATIVE DERMATOLOGY, 2005
Histologic similarities between lentigo malig and dysplastic nevus
JOURL OF CUTANEOUS PATHOLOGY, 2005
Malignt Melanoma
eMedicine Jourl [serial online]. Available at: http://www.emedicine.co
Prevention and detection of melanoma in the primary care setting.
J Clin Outcomes Magement, 2005
Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical alysis of cutaneous lesions
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004
Challenge. Epithelioid cell histiocytoma.
American Jourl of dermatopathology, 2003
Malignt melanoma
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003
Current magement of melanoma: Benefits of surgical staging and adjuvant therapy
JOURL OF SURGICAL ONCOLOGY, 2003
Dermatological perspectives of malignt melanoma
SURGICAL CLINICS OF NORTH AMERICA, 2003
Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas
JOURL OF CUTANEOUS PATHOLOGY, 2003
Positron emission tomography is superior to computed tomography for metastatic detection
ANLS OF SURGICAL ONCOLOGY, 2002
Interstitial mycosis fungoides
JOURL OF CUTANEOUS PATHOLOGY, 2002
The ratiole behind the 2002 AJCC Melanoma Staging Committee recommendations
The Melanoma Letter, 2001
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
TURE MEDICINE, 1999
Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma
JOURL OF CUTANEOUS PATHOLOGY, 1998
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant
JOURL OF INFECTIOUS DISEASES, 1998
Increased proportion of aggressive
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996
Malignt melanoma from the dermatologic perspective
SURGICAL CLINICS OF NORTH AMERICA, 1996
Surgical margins for malignt melanoma: Another point of view
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996
Cutaneous myiasis following travel to Belize
INTERTIOL JOURL OF DERMATOLOGY, 1996
CUTANEOUS NODULES OF MYCOBACTERIUM
JOURL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993
Melanoma, Version 4.2014 Featured Updates to the NCCN Guidelines
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014
Pediatric Melanoma: Analysis of an International Registry
CANCER, 2013
Role of aspirin and non-aspirin NSAIDs in preventing melanoma.
Future oncology, 2013
Activating HRAS Mutation in Agminated Spitz Nevi Arising in a Nevus Spilus.
JAMA dermatology, 2013
Melanoma Survival Disadvantage in Young, Non-Hispanic White Males Compared With Females
JAMA DERMATOLOGY, 2013
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's
CANCER, 2013
Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma
CANCER, 2012
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
TRANSLATIONAL ONCOLOGY, 2012
Screening and Prevention Measures for Melanoma: Is There a Survival Advantage?
CURRENT ONCOLOGY REPORTS, 2012
Examining the pathways linking lower socioeconomic status and advanced melanoma
CANCER, 2012
Behavioral determinants of successful early melanoma detection
CANCER, 2012
Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling
JOURNAL OF CLINICAL ONCOLOGY, 2012
Survival Is Not the Only Valuable End Point in Melanoma Screening
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012
Reporting and registering nonmelanoma skin cancers: a compelling public health need
BRITISH JOURNAL OF DERMATOLOGY, 2012
Melanoma
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012
Attitudes Toward Indoor Tanning Among Users of Sunless Tanning Products
ARCHIVES OF DERMATOLOGY, 2012
Guidelines of care for the management of primary cutaneous melanoma
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011
Reducing mortality in individuals at high risk for advanced melanoma through education
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011
Increases in Melanoma Among Adolescent Girls
ARCHIVES OF DERMATOLOGY, 2011
Effect of oral sulindac on biomarkers of drug bioavailability
Curiel-Lewandrowski, C., Swetter, S., Einspahr, J., Hsu, C., Saboda, K, 2011
The Expanding Melanoma Burden in California Hispanics Importance of Socioeconomic Distribution
CANCER, 2011
Interaction of Area-Level Socioeconomic Status
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010
Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children
PEDIATRIC DERMATOLOGY, 2010
Risk of second primary malignancies following cutaneous melanoma diagnosis
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010
Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer
JOURNAL OF CUTANEOUS PATHOLOGY, 2010
Efficacy of Skin Self-Examination Practices for Early Melanoma Detection
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009
Selection criteria for genetic assessment of patients with familial melanoma
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009
Increasing Burden of Melanoma in the United States
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009
Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis
JOURNAL OF CUTANEOUS PATHOLOGY, 2009
Impaired interferon signaling is a common immune defect in human cancer
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2009
Factors Associated With Physician Discovery of Early Melanoma in Middle-aged and Older Men
ARCHIVES OF DERMATOLOGY, 2009
Gender Differences in Melanoma Awareness and Detection Practices Between Middle
ARCHIVES OF DERMATOLOGY, 2009
Melanoma in Middle-aged
ARCHIVES OF DERMATOLOGY, 2009
Factors Related to the Presentation of Thin
CANCER, 2009
Melanoma
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009
High-molecular-weight keratin stain as a complement to Melan A stain
JOURNAL OF CUTANEOUS PATHOLOGY, 2008
Melanoma underreporting: Why does it happen, how big is the problem, and how do we fix it?
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008
California medicaid Enrollment and melanoma stage at diagnosis - A population-based study
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2008
Primary dermal melanoma
ARCHIVES OF DERMATOLOGY, 2008
Screening, early detection
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007
Evaluation of digital dermoscopy in a pigmented lesion clinic
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007
Effect of health care delivery models on melanoma thickness
ARCHIVES OF DERMATOLOGY, 2007
Crafting a melanoma educational campaign to reach middle-aged and older men
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2006
Facial resurfacing for nonmelanoma skin cancer prophylaxis
ARCHIVES OF DERMATOLOGY, 2006
Slow-growing nodule on the thigh - Solitary fibrous tumor (SFT)
ARCHIVES OF DERMATOLOGY, 2006
Use of artificial tanning products among young adults
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006
Sun care advertising in popular US magazines
AMERICAN JOURNAL OF HEALTH PROMOTION, 2006
A call for the development and implementation of a targeted national melanoma screening program
ARCHIVES OF DERMATOLOGY, 2006
Sun protection factor content and warning statements for sunless tanning products
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005
Increasing incidence of lentigo maligna melanoma subtypes
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005
Sentinel lymph node biopsy for cutaneous melanoma - The Stanford experience, 1997-2004
ARCHIVES OF DERMATOLOGY, 2005
Histologic similarities between lentigo maligna and dysplastic nevus
JOURNAL OF CUTANEOUS PATHOLOGY, 2005
Malignant Melanoma
eMedicine Journal [serial online]. Available at: http://www.emedicine.
Vaccine therapy of melanoma: an update.
Current Cancer Therapy Reviews, 2005
Prevention and detection of melanoma in the primary care setting.
J Clin Outcomes Management, 2005
Melanoma in the older person
ONCOLOGY-NEW YORK, 2004
Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome
DERMATOLOGIC SURGERY, 2004
Diffuse verrucous, vascular nodules on the extremities and trunk
ARCHIVES OF DERMATOLOGY, 2004
Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004
Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis
ARCHIVES OF DERMATOLOGY, 2004
Primary dermal melanoma - A distinct subtype of melanoma
ARCHIVES OF DERMATOLOGY, 2004
Challenge. Epithelioid cell histiocytoma.
American Journal of dermatopathology, 2003
Malignant melanoma
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003
Current management of melanoma: Benefits of surgical staging and adjuvant therapy
JOURNAL OF SURGICAL ONCOLOGY, 2003
Dermatological perspectives of malignant melanoma
SURGICAL CLINICS OF NORTH AMERICA, 2003
Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas
JOURNAL OF CUTANEOUS PATHOLOGY, 2003
Increased effectiveness of targeted skin cancer screening
PREVENTIVE MEDICINE, 2003
Positron emission tomography is superior to computed tomography for metastatic detection
ANNALS OF SURGICAL ONCOLOGY, 2002
Interstitial mycosis fungoides
JOURNAL OF CUTANEOUS PATHOLOGY, 2002
Developing indications for the use of sentinel lymph node biopsy
ARCHIVES OF DERMATOLOGY, 2001
The rationale behind the 2002 AJCC Melanoma Staging Committee recommendations
The Melanoma Letter, 2001
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
NATURE MEDICINE, 1999
Hereditary ochronosis: Hyperpigmented skin overlying cartilaginous structures
CUTIS, 1999
Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma
JOURNAL OF CUTANEOUS PATHOLOGY, 1998
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant
JOURNAL OF INFECTIOUS DISEASES, 1998
Dopamine-associated symmetric peripheral gangrene
ARCHIVES OF DERMATOLOGY, 1997
Increased proportion of aggressive
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996
Malignant melanoma from the dermatologic perspective
SURGICAL CLINICS OF NORTH AMERICA, 1996
Surgical margins for malignant melanoma: Another point of view
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996
Cutaneous myiasis following travel to Belize
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996
SCLEREDEMA REVISITED - A POSTSTREPTOCOCCAL COMPLICATION
CLINICAL PEDIATRICS, 1994
CUTANEOUS NODULES OF MYCOBACTERIUM
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993
What is Dr. Swetter's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Swetter's National Provider Identifier (NPI) number is 1538172051.
What common questions do patients ask about Dr. Swetter?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Swetter
What is Dr. Susan Swetter's specialty?
Dr. Swetter is a Dermatologist near Stanford, CA. Dermatologists are medical professionals trained to diagnose and treat a wide range of skin conditions in both children and adults, including skin cancers, melanomas, and other tumors. They also manage disorders of the mouth, external genitalia, hair, and nails, and are skilled in treating conditions like dermatitis, allergic reactions, and skin manifestations of systemic diseases. Dermatologists receive specialized training in dermatopathology and dermatologic surgical techniques, and address cosmetic issues such as hair loss and scarring. Additionally, they use laboratory methods to diagnose immune-related skin disorders, often collaborating with immunohematologists for expert consultation and targeted therapies. Contact Dr. Swetter to book an appointment today.
Is this Dr. Susan Swetter affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Swetter is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Dermatologist?
Explore Dermatologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Susan Swetter accepting new patients in Stanford, CA?
Yes, Dr. Susan Swetter is accepting new patients at this time.
Does Dr. Susan Swetter offer online booking?
Please contact Dr. Swetter's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Susan Swetter?
Please contact Dr. Swetter's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Susan Swetter have?
Dr. Susan Swetter is certified by the American Board of Dermatology.
Other Dermatologist Near Stanford, CA
Dermatologist
Accepting patientsDermatologist
Accepting patientsDermatologist
Accepting patients